Yale University School of Medicine, New Haven, Connecticut, USA.
Curr Opin Anaesthesiol. 2021 Jun 1;34(3):326-334. doi: 10.1097/ACO.0000000000000986.
An increasing number of patients with endocrine disorders will present to the operating rooms. In this review, we outline the common endocrine disorders that the anesthesiologist may face in the perioperative time span, review the controversies in optimal management, as well as summarize the recent literature for the management of these complex patients.
Perioperative management of pheochromocytoma and paraganglioma has been facilitated by improved medical management and the adoption of minimally invasive surgical techniques. An improved understanding of the sequelae of carcinoid syndrome has resulted in safer perioperative management. Perioperative glycemic management requires a fundamental understanding of perioperative fluid resuscitation and adverse events associated with the new generation oral hyperglycemic agents to prevent avoidable complications.
Endocrine disorders will commonly present in the perioperative time period and the anesthesiologist plays a critical role in achieving good operative outcomes.
越来越多的内分泌疾病患者将在手术室接受治疗。在这篇综述中,我们概述了麻醉师在围手术期可能遇到的常见内分泌疾病,回顾了最佳治疗方法中的争议,并总结了最近关于这些复杂患者管理的文献。
通过改进的医学管理和微创外科技术,嗜铬细胞瘤和副神经节瘤的围手术期管理变得更加容易。对类癌综合征后遗症的认识的提高导致了更安全的围手术期管理。围手术期血糖管理需要对围手术期液体复苏和与新一代口服降糖药相关的不良事件有基本的了解,以预防可避免的并发症。
内分泌疾病在围手术期很常见,麻醉师在获得良好手术效果方面起着关键作用。